Journal of Haehwa Medicine (혜화의학회지)
- Volume 17 Issue 2
- /
- Pages.137-148
- /
- 2008
- /
- 2586-3002(pISSN)
- /
- 2586-3347(eISSN)
Suppressive Effects of Jauijeonhotang(JHG) on Immune cells in BALF of OVA-sensitized Balb/c Mice
자의전호탕(自擬前胡湯)이 천식 모델 생쥐의 BALF 내 관련 면역세포 변화에 미치는 영향
- Hong, Sang-Cheol (Department of Oriental Pathology, College of Oriental Medicine, Daejeon University) ;
-
Choi, Hak-Joo
(Department of Oriental Pathology, College of Oriental Medicine, Daejeon University) ;
- Gim, Seon-Bin (Department of Oriental Pathology, College of Oriental Medicine, Daejeon University) ;
-
Kim, Dong-Hee
(Department of Oriental Pathology, College of Oriental Medicine, Daejeon University)
- 홍상철 (대전대학교 한의과대학 병리학교실) ;
-
최학주
(대전대학교 한의과대학 병리학교실) ;
- 김선빈 (대전대학교 한의과대학 병리학교실) ;
-
김동희
(대전대학교 한의과대학 병리학교실)
- Published : 2008.12.31
Abstract
In order to investigate the effects of JHG on immune cells in BALF, clinically prescribed JHG was tested using OVA induced asthma animal model. The results are shown below: 1. JHG significantly reduced the total number of cells in BALF compared to that of the control at 400 mg/kg doses. 2. JHG significantly reduced the number of CD3+/CD69+ cells in BALF at 400 and 200 mg/kg doses. 3. JHG significantly reduced the number of CCR3+ cells in BALF at 400 and 200 mg/kg doses. 4. JHG significantly reduced the number of B220+/CD22+ cells in BALF at 400 and 200 mg/kg doses. 5. JHG significantly reduced the number of B220+/IgE+ cells in BALF at 400 and 200 mg/kg doses. 6. JHG significantly reduced the number of B220+/CD45+ cells in BALF at 400 and 200 mg/kg doses. From the results above, anti-asthmatic efficacy of JHG through anti-oxidative activity as well as immune control activity has been experimentally proven. In depth study of JHG on various pathological factors and individual drug contents of JHG should follow.